Questions about how individual parts of claim 1 might be changed. A question may describe something different from what the claim language recites, or a version of it; no view is offered on which.
1.1Four methylenes before the amide
What ifWhat if four methylene units connected the chelating scaffold to the amide carbonyl?
Claim language“m is an integer of from 1 to 3”
A pendant carboxylic acid with a four-methylene spacer couples to 3-amino-1,2-propanediol to form the amide. The spacer separates the diol from the metal-binding site, and the two hydroxyl groups hydrogen-bond with water.
1.2Fluorine at the R2 position
What ifWhat if a covalently bound fluorine atom occupied R2, with hydrogen at R3 and R4?
Claim language“a C1-C3 alkyl group”
The synthesis incorporates the fluorinated scaffold building block before adding Mn2+. The scaffold donor atoms bind Mn2+, and the manganese center accelerates relaxation of nearby water protons.
1.2Carboxamide at the R3 position
What ifWhat if a primary carboxamide attached through its carbonyl carbon occupied R3, with hydrogen at R2 and R4?
Claim language“a C1-C3 alkoxy group”
An R3 ester serves as the precursor to the primary carboxamide, which forms by reaction with ammonia before metal loading. The pendant carbonyl oxygen accepts hydrogen bonds from water, and the amide N–H bonds donate them.
1.3Single stereoisomer from chiral feedstock
What ifWhat if the chelate preparation contained a single stereoisomer?
Claim language“mixtures of same”
An enantiopure 3-amino-1,2-propanediol supplies the hydroxyl-bearing stereocenter during amide coupling. After manganese coordination, preparative chiral liquid chromatography separates the target chelate stereoisomer from other resolved stereoisomers.
Section 2 · machine-generated
Variations
Further arrangements of the same subject matter, described here as of the publication date at the foot of this page.
Other field of use
Magnetic resonance mapping of porous rock
A flow cell holds a porous rock core between two fluid distributors. A pump delivers a step change from background brine to brine containing the manganese(II) polyol chelate at the same salinity. Serial longitudinal relaxation maps track the advancing tracer front, using a calibration series prepared in the same brine and measured at the core temperature.
Component substitution
Ether linkage in the polyol pendant
The manganese(II) complex retains the chelating core and uses a —CH₂—CH₂—O—CH₂—CH(OH)—CH₂OH pendant in place of the amide-linked pendant. The ether connects the two-carbon spacer to the terminal diol. The isolated complex is dissolved in buffered water, and its longitudinal relaxivity is measured from the slope of relaxation rate against manganese concentration.
Parameter or scale variation
Three methylene spacer with terminal alcohol
The manganese(II) complex uses m = 3 and n = 0, giving the pendant —(CH₂)₃—C(═O)—NH—CH₂—CH₂OH. R2 and R4 are hydrogen, and R3 is methyl. A dilution series from 0.05 to 0.50 mmol/L manganese in pH 7.4 buffer provides longitudinal relaxation measurements at 37 °C.
Two field strengths for chelate calibration
Sealed vials hold the same manganese(II) polyol chelate at 0, 0.10, 0.25, 0.50 and 1.00 mmol/L in buffered water. The same vial set is imaged at 1.5 T and 3.0 T after equilibration to 22 °C at each instrument. An inversion recovery series supplies a longitudinal relaxation time for each vial, and a separate concentration fit gives relaxivity at each field strength.
Combination with existing systems
Tracer injection in a perfusion phantom
A recirculating magnetic resonance perfusion phantom contains a reservoir, a pump, an injection port and parallel flow channels. The injection port delivers a measured bolus of the manganese(II) polyol chelate upstream of the channel splitter. Dynamic images record bolus arrival and passage in each channel, and a pump-driven flush restores the baseline between runs.
Automated or data-driven variant
Automated measurement of manganese chelate relaxivity
A liquid-handling robot dispenses chelate stock and buffer into a rack of sealed sample tubes at programmed dilution ratios. A magnetic resonance relaxometer measures longitudinal relaxation time for each tube at a fixed temperature. Software fits reciprocal relaxation time against manganese concentration and reports the slope, fit residuals and blank measurement.
Specific version of a part
Polyether segment with terminal hydroxyl
An amino-terminated diethylene glycol derivative supplies the side chain –NH–CH₂CH₂–O–CH₂CH₂–OH after amide coupling. The ether oxygen accepts hydrogen bonds from water, and the terminal hydroxyl both donates and accepts them.
Three methylenes and six hydroxyls
The side chain uses m = 3 and n = 5. Three methylene units connect the scaffold to the amide carbonyl, and five hydroxyl-bearing methine units plus a terminal hydroxymethyl group provide six hydroxyl groups.
Methyl and ethoxy substituent pair
R2 is methyl, R3 is ethoxy, and R4 is hydrogen. The ethoxy group attaches to the scaffold through oxygen, and the methyl group attaches through carbon.
Dihydrate with lattice water
A crystalline dihydrate contains two lattice water molecules per chelate formula unit. Thermogravimetric analysis measures the mass loss on dehydration, and single-crystal X-ray diffraction locates the water oxygen atoms in the lattice.
Section 3 · quoted from USPTO records
Other work
Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
1.1m is an integer of from 1 to 3 and n is an integer of from 0 to 5
1.2R2, R3 and R4 are each individually selected from a hydrogen atom, a C1-C3 alkyl group and a C1-C3 alkoxy group
This object is achieved by phosphorus-modified silanes which contain at least one methoxy group bound to the silicon and have the general formula I: where the radicals R1 are each, independently of one another, a substituted or unsubstituted alkyl, alkenyl, cycloalkyl or aryl group having from 1 to 18 carbon atoms or an alkoxy group having from 2 to 18 carbon atoms, R2 is a methoxy group, the radicals R4 are each, independently of one another, hydrogen, an alkyl, cycloalkyl o
A · US 2006/0247409 A1 · ¶ 10
1.3stereoisomers, tautomers, N-oxides, hydrates, solvates, or salts thereof, or mixtures of same.
The triterpene derivatives of Formula (Ia), as disclosed above herein, also comprise their analogs, derivatives, tautomeric forms, isomers, stereoisomers, polymorphs, pharmaceutically acceptable salts or pharmaceutically acceptable solvates.
B · US 10,766,855 B2 · ¶ 65
An empty cell means only that no passage was reproduced there.
Statements in these documents
They can be used, for example, as bonding agents, as crosslinkers, for the functionalization of silicones, silicone resins such as silesquioxanes or metal oxides such as pyrogenic silicas or for modifying the properties of glycols.
A · US 2006/0247409 A1 · ¶ 2
A disadvantage of this reaction is that long reaction times and high temperatures are required, which leads to rearrangements in the product and thus to losses in yield.
A · US 2006/0247409 A1 · ¶ 5
Furthermore, the present invention relates to their use as a medicament and in therapy, particularly as stabilizer of HIF-1α and HIF-2α proteins, activator of the HIF-1 pathway and in treating diseases and conditions responsive to HIF-1α and HIF-2 stabilization.
B · US 10,766,855 B2 · ¶ 2
Such observations, along with the previous report that HIF enhanced EPO release and concomitantly increased erythropoiesis, imply that activation of HIF by modulating PHDs could be beneficial for patients with anemia and ischemia-related diseases.
B · US 10,766,855 B2 · ¶ 5
Cite aspatent.fyi, US 2026/0356867 A1, claim 1, first published 2026-11-20T08:11:50-05:00, https://patent.fyi/US20260356867/, SHA-256 3cf0b05a36f6c586d56f99886c101639b5f55fb23aedbea53eb00b6da65f89f1